company

STAVANGER KIROPRAKTORKLINIKK OG NEVROSENTER AS

4015 STAVANGER

Return on Equity
84,78 %
Current Ratio
1,02
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue1 462 000
Net Income78 000
Total Assets309 000
Total Equity92 000
Income (NOK)2022
Revenue1 462 000
Expenditure1 385 000
Operating Profit77 000
Financial Income1 000
Financial Costs0
Financial Balance1 000
Earnings Before Tax78 000
Tax0
Net Income78 000
Balance (NOK)2022
Total Fixed Assets87 000
Total Current Assets222 000
Total Assets309 000
Total Retained Equity42 000
Total Equity92 000
Total Long-Term Debt0
Total Current Debt217 000
Total Equity and Debt309 000
Cash flow (NOK)2022
Sales Income1 270 000
Other Income192 000
Revenue1 462 000
Cost of Goods Sold6 000
Salary Costs1 048 000
Depreciation22 000
Impairment0
Expenditure1 385 000
Operating Profit77 000
Financial Income1 000
Financial Costs0
Financial Balance1 000
Dividends0
Net Income78 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures87 000
Total Tangible Assets87 000
Total Fiancial Fixed Assets0
Total Fixed Assets87 000
Stock3 000
Total Investments0
Cash, Bank106 000
Total Current Assets222 000
Total Assets309 000
Total Equity92 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors24 000
Unpaid Taxes99 000
Dividends0
Other Current Debt95 000
Total Current Debt217 000
Total Equity and Debt309 000
Financial indicators2022
Return on Equity84,78 %
Debt-to-Equity Ratio0
Operating Profit Margin5,27 %
Current Ratio1,02
Quick Ratio1,04
Equity Ratio0,3
Gross Profit Margin99,59 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English